Actively Recruiting
Exploring Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma A Prospective Treatment Trial
Led by Oslo University Hospital · Updated on 2026-10-16
15
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether liver transplantation can improve survival, reduce side effects, and enhance quality of life for patients with bile duct cancer that cannot be removed by regular surgery. The study focuses on perihilar cholangiocarcinoma, a rare and aggressive cancer of the bile ducts, where only about 20% of patients are eligible for surgical removal. The research also includes analyzing blood and tumor tissue samples to understand which patients might experience disease recurrence after transplantation, as well as studying the effects of chemotherapy on liver and tumor tissues removed during transplant. Participants will undergo liver transplantation following standard institutional procedures performed by specialized surgeons. The surgery involves careful exploration and assessment of lymph nodes to confirm eligibility and avoid transplantation if the cancer has spread to specific lymph nodes. The transplantation process uses a multimodal approach that may include prior chemotherapy and radiation. This study builds on previous results demonstrating improved survival with liver transplantation for this cancer type. During the study, participants will be closely monitored with assessments of overall survival up to 36 months after inclusion and disease-free survival for up to 10 years following transplantation. Researchers will also track time to new treatments, quality of life measures, complications within 90 days after surgery, diagnosis of other cancers, and survival in relation to biological markers. The total participation duration may extend over a decade to evaluate long-term outcomes and safety.
CONDITIONS
Brief Title
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
Research Team
S
Sheraz Yaqub, MD PhD
P
Pål-Dag Line, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here